Intrinsiqq
Lexeo Therapeutics Inc. logo

Lexeo Therapeutics Inc. Insider Trading

LXEO

Compare
Last 12 months

Insiders sold 739K and bought nothing on the open market.

42% of the selling was scheduled in advance under 10b5-1 plans. Chief Medical Officer Narinder Pal Bhalla sold 99K on Jul 1, 21% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2024.

Net open-market
−739K
0 buys · 15 sales
Under a 10b5-1 plan
42%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
Nov 2024
Nov 25, 2024

Get an email when LXEO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 17No plan
    Louis Edward Tamayo
    Chief Financial Officer · sold 1,007 at $3.26
    3K
    1.1% of stake
  • Nov 17No plan
    Jose Manuel Otero
    Chief Operating Officer · sold 1,285 at $3.26
    4K
    0.9% of stake
  • Nov 17No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 3,295 at $3.26
    11K
    0.9% of stake
  • Aug 18No plan
    Louis Edward Tamayo
    Chief Financial Officer · sold 4,117 at $4.91
    20K
    4.2% of stake
  • Aug 18No plan
    Jose Manuel Otero
    Chief Operating Officer · sold 1,304 at $4.96
    6K
    0.9% of stake
  • Aug 18No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 3,345 at $4.95
    17K
    0.9% of stake
  • Jul 1No plan
    Narinder Pal Bhalla
    Chief Medical Officer · sold 22,306 at $4.42
    99K
    21% of stake
  • Jul 1No plan
    Louis Edward Tamayo
    Chief Financial Officer · sold 4,641 at $4.49
    21K
    4.6% of stake
  • Jul 1No plan
    Jose Manuel Otero
    Chief Operating Officer · sold 4,666 at $4.48
    21K
    3.3% of stake
  • Jul 1No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 25,947 at $4.48
    116K
    6.4% of stake
  • May 18No plan
    Jose Manuel Otero
    Chief Operating Officer · sold 1,302 at $5.07
    7K
    1.0% of stake
  • May 18No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 3,342 at $5.06
    17K
    1.0% of stake
  • Apr 610b5-1 plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 55,000 at $5.69
    313K
    14% of stake
  • Feb 18No plan
    Jose Manuel Otero
    Chief Operating Officer · sold 3,016 at $6.40
    19K
    2.3% of stake
  • Feb 18No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 10,173 at $6.38
    65K
    2.5% of stake
  • Nov 18, 2025No plan
    Jose Manuel Otero
    Chief Operating Officer · sold 721 at $9.27
    7K
    1.1% of stake
  • Nov 18, 2025No plan
    Tai Sandi See
    Chief Development Officer · sold 386 at $9.27
    4K
    0.6% of stake
  • Nov 18, 2025No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 1,127 at $9.27
    10K
    0.5% of stake
  • Nov 18, 2025No plan
    Jenny Robertson
    Chief Legal Officer · sold 549 at $9.27
    5K
    0.8% of stake
  • Nov 18, 2025No plan
    Eric Adler
    Chief Medical Officer · sold 615 at $9.27
    6K
    0.8% of stake
  • Oct 17, 2025No plan
    Jose Manuel Otero
    Chief Technical Officer · sold 2,115 at avg $8.95
    19K
    3.2% of stake
  • Oct 17, 2025No plan
    Tai Sandi See
    Chief Development Officer · sold 3,888 at avg $8.95
    35K
    5.6% of stake
  • Oct 17, 2025No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 13,133 at avg $8.95
    118K
    5.1% of stake
  • Oct 17, 2025No plan
    Jenny Robertson
    Chief Legal Officer · sold 3,526 at avg $8.95
    32K
    4.9% of stake
  • Oct 17, 2025No plan
    Eric Adler
    Chief Medical Officer · sold 3,382 at avg $8.95
    30K
    4.4% of stake
  • Aug 18, 2025No plan
    Jose Manuel Otero
    Chief Technical Officer · sold 721 at $9.27
    7K
    1.1% of stake
  • Aug 18, 2025No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 1,115 at $4.67
    5K
    0.5% of stake
  • Aug 18, 2025No plan
    Jose Manuel Otero
    Chief Technical Officer · sold 2,848 at $4.67
    13K
    4.5% of stake
  • Aug 18, 2025No plan
    Jenny Robertson
    Chief Legal Officer · sold 542 at $4.67
    3K
    0.9% of stake
  • Aug 18, 2025No plan
    Eric Adler
    Chief Medical Officer · sold 608 at $4.67
    3K
    0.9% of stake
  • Aug 18, 2025No plan
    Tai Sandi See
    Chief Development Officer · sold 382 at $4.67
    2K
    0.6% of stake
  • May 16, 2025No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 1,074 at $2.77
    3K
    0.5% of stake
  • May 16, 2025No plan
    Eric Adler
    Chief Medical Officer · sold 585 at $2.77
    2K
    0.9% of stake
  • May 16, 2025No plan
    Jenny Robertson
    Chief Legal Officer · sold 521 at $2.77
    1K
    0.8% of stake
  • May 16, 2025No plan
    Tai Sandi See
    Chief Development Officer · sold 367 at $2.77
    1K
    0.6% of stake
  • Feb 19, 2025No plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 4,326 at $4.41
    19K
    1.9% of stake
  • Feb 19, 2025No plan
    Tai Sandi See
    Chief Development Officer · sold 1,486 at $4.41
    7K
    2.7% of stake
  • Feb 19, 2025No plan
    Eric Adler
    Chief Medical Officer · sold 2,359 at $4.41
    10K
    3.3% of stake
  • Feb 19, 2025No plan
    Jenny Robertson
    Chief Legal Officer · sold 2,101 at $4.41
    9K
    3.5% of stake
  • Dec 10, 202410b5-1 plan
    Richard Nolan Townsend
    Chief Executive Officer · sold 2,500 at $8.20
    21K
    2.0% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LXEO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LXEO

CompareIntrinsic value
CRDFCardiff Oncology Inc.
$0.85-4.18%36
PROKProKidney Corp
$1.04-1.89%10
IMAImageneBio, Inc.
$3.92-1.51%10
PALIPalisade Bio Inc.
$0.84-9.69%20
CMPXCompass Therapeutics Inc.
$0.69+1.40%10
ARMPArmata Pharmaceuticals Inc.
$3.03+1.68%30
BCABBioAtla, Inc.
$1.55+20.16%0
CVMCel-Sci Corporation
$1.21-17.69%0

Held by ETFs

LXEO is in 14 US ETFs. The largest of them, with LXEO's weight in each:

Spot a number that looks wrong? Check it in LXEO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing LXEO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.